Published in Blood Weekly, September 16th, 2004
"The structural component of Gram bacteria," ET "induces the release of endogenous mediators of sepsis," scientists in California explained. "Attempts to remove these downstream molecules in vivo have not improved survival."
"However, extracorporeal strategies such as continuous renal replacement therapy or therapeutic plasmapheresis have shown benefit," noted M.C. Amoureux and colleagues at Carlsbad-based Clarigen Inc., who developed "an affinity-based extracorporeal technology for the removal of ET from whole blood."
"The small-scale device...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.